Clinical Trial: Safety Evaluation of a Q-fever Vaccine, NDBR 105
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Continued Evaluation of the Safety of Q Fever Vaccine, Phase I, Inactivated, Freeze Dried, NDBR 105, in Those at Risk of Exposure to Coxiella Burnetii, A Phase 2 Study
Brief Summary: The purpose of this study is to evaluate the safety of Q Fever vaccine, NDBR 105, and collect data on incidence of occupational Q Fever infection in at risk personnel.
Detailed Summary:
Study Objectives:
1. Continue to collect and assess safety data on Q Fever Vaccine, Phase I, Inactivated, Freeze-Dried, NDBR 105, and 2) Provide vaccine that potentially protects personnel at risk for occupational exposure to Q Fever and collect data on incidence of occupational Q Fever infection (subclinical and clinical) in immunized personnel.
Sponsor: U.S. Army Medical Research and Materiel Command
Current Primary Outcome: The Adverse Reaction and Occupational Illness Endpoint Measurements in This Q Fever NDBR 105 Vaccine Study Will be Evaluated for All Intent-to-treat Volunteers. [ Time Frame: AEs recorded through day 28 after vaccination; SAEs recorded through duration of study; Confirmed occupational illness recorded through duration of study ]
Original Primary Outcome: The Adverse Reaction and Occupational Illness Endpoint Measurements in This Q Fever NDBR 105 Vaccine Study Will be Evaluated for All Intent-to-treat Volunteers. [ Time Frame: AEs recorded through day 28 after vaccination; SAEs recorded through duration of study; Confirmed occupational illness recorded through duration of study ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: U.S. Army Medical Research and Materiel Command
Dates:
Date Received: December 20, 2007
Date Started: February 2006
Date Completion:
Last Updated: January 18, 2017
Last Verified: January 2017